According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is A$3.10 Billion. In 2022 the company made a revenue of A$2.81 Billion a decrease over the revenue in the year 2021 that were of A$3.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.